Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 23 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

9%

2 trials in Phase 3/4

Results Transparency

24%

4 of 17 completed with results

Key Signals

4 with results100% success

Data Visualizations

Phase Distribution

21Total
Not Applicable (16)
P 1 (3)
P 4 (2)

Trial Status

Completed17
Unknown2
Withdrawn2
Not Yet Recruiting1
Active Not Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 17 completed trials

Clinical Trials (23)

Showing 20 of 20 trials
NCT06152718Not ApplicableCompletedPrimary

New Regenerative Approach for Dermal Renovation (Karisma)

NCT06291415Phase 1Withdrawn

The Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HMPL-523 in Adult Subjects With Immune Thrombocytopenia (ITP)

NCT05987163Not ApplicableActive Not RecruitingPrimary

Study to Evaluate the Safety and Effectiveness of GP0116

NCT06891924Not ApplicableNot Yet Recruiting

A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine

NCT06188338Not ApplicableCompletedPrimary

A 56-day Clinical Study on Facial Skin Rejuvenation

NCT06140628Not ApplicableCompleted

A 28-day Clinical Study on Facial Skin Rejuvenation

NCT05872178Not ApplicableCompletedPrimary

Omegia Softgel Clinical Research Program

NCT05597254Not ApplicableCompleted

Facial Skin Clinical and Microbial Profiling From Oral Probiotic Supplementation

NCT01046565Phase 1CompletedPrimary

Tolerability Comparison Between Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

NCT01046396Phase 1CompletedPrimary

Tolerability Comparison of Differin® Cream 0.1% Versus Differin® Lotion 0.1% in Subjects With Healthy Skin

NCT01139008Phase 4CompletedPrimary

Split-Face Tolerability Comparison Between MetroGel® 1% Versus Finacea® 15% in Subjects With Healthy Skin

NCT01139047Phase 4CompletedPrimary

Split-face Tolerability Comparison Between MetroGel® 1% vs Finacea® 15% in Subjects With Healthy Skin

NCT05235997Not ApplicableUnknown

Placebo Controlled Efficacy Evaluation of the Hydrolyzed Collagen Peptide In Adult Females

NCT05094687Completed

Cutaneous Manifestations of Coronavirus Disease 2019(COVID-19).

NCT04344119UnknownPrimary

Assessment of Chilbains Occuring During Covid-19 Infection

NCT04701463Not ApplicableCompleted

A Specialized Amino Acid Mixture on Body Composition and Skin State in Overweight and Obese Class I Postmenopausal Women

NCT04449159Not ApplicableCompletedPrimary

Efficacy of Vinh Wellness Collagen on Skin Health

NCT04154436Not ApplicableCompletedPrimary

Effectiveness, Safety, and Cost Efficacy of Water (H2O) as a Substitute for Sodium Bicarbonate (NaHCO3) Plus Solution in Neutralization of Chemical Peeling Using 35% Glycolic Acid Solution

NCT03873896Not ApplicableCompletedPrimary

The Skin Wrinkle Test: a Simple Clinical Test of Regional Block Success

NCT04002856Not ApplicableCompletedPrimary

Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck

Scroll to load more

Research Network

Activity Timeline